HOLX: מכפיל PEG Hologic, Inc.

Hologic, Inc. (HOLX) maintains global leadership in mammography and molecular testing, which successfully offsets its narrow specialization in women's health. The GURU.Markets system calculates the PEG ratio, where the parameter has stabilized at 2.57. Market capitalization is based on 3D scanners and gynecological surgery, while expansion into foreign markets alongside M&A transactions stimulates further business development.

The PEG ratio compares the current market value of a share with the growth rate of net income, allowing for the identification of undervalued assets when values fall below one. Analyzing historical PEG levels helps filter out market noise and confirm trend sustainability, which is particularly relevant for Hologic, Inc. (HOLX), whose service revenue model from proprietary tests and mammography systems provides a stable foundation for long-term growth.